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Objective: To assess undiagnosed and comorbid disorders in patients referred to a tertiary care center with a pre-
sumed diagnosis of chronic fatigue syndrome (CFS).
Methods: Patients referred for chronic unexplained fatigue entered an integrated diagnostic pathway, including in-
ternal medicine assessment, psychodiagnostic screening, physiotherapeutic assessment and polysomnography +
multiple sleep latency testing. Final diagnosis resulted from a multidisciplinary team discussion. Fukuda criteria
were used for the diagnosis of CFS, DSM-IV-TR criteria for psychiatric disorders, ICSD-2 criteria for sleep disorders.
Results:Out of 377 patients referred, 279 (74.0%) were included in the study [84.9% female; mean age 38.8 years
(SD 10.3)].
A diagnosis of unequivocal CFS was made in 23.3%. In 21.1%, CFS was associated with a sleep disorder and/or psy-
chiatric disorder, not invalidating the diagnosis of CFS. A predominant sleep disorder was found in 9.7%, 19.0% had
a psychiatric disorder and 20.8% a combination of both. Only 2.2% was diagnosed with a classical internal disease.
In the total sample, a sleep disorderwas found in 49.8%, especially obstructive sleep apnea syndrome, followed by
psychophysiologic insomnia and periodic limbmovement disorder. A psychiatric disorderwas diagnosed in 45.2%;
mostly mood and anxiety disorder.
Conclusions: A multidisciplinary approach to presumed CFS yields unequivocal CFS in only a minority of patients,
and reveals a broad spectrum of exclusionary or comorbid conditions within the domains of sleep medicine and
psychiatry. These ﬁndings favor a systematic diagnostic approach to CFS, suitable to identify a wide range
of diagnostic categories that may be subject to dedicated care.© 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.edicine; AHI, apnea-hypopnea
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Chronic fatigue syndrome (CFS) is characterized by long lasting,
unexplained fatigue with a disabling impact on professional, social
and daily functioning. The absence of any obvious underlying disease
and the presence of a number of associated clinical features are funda-
mental to this disorder. Several case deﬁnitions have been introduced,
including the revised CDC (Centers for Disease Control and Prevention)
criteria published by Fukuda et al. in 1994 [1]. These are now the stan-
dard criteria in the US and are widely used in other countries as well.
To establish the diagnosis of CFS, the Fukuda deﬁnition requires a
major criterion of unexplained, incapacitating fatigue of at least six
month duration, in combination with at least four out of eight minor
criteria. These minor criteria include postexertional malaise lasting for
at least 24 h, sore throat, tender cervical or axillary lymph nodes,
muscle pain, multi-joint pain without swelling or redness, headache of
a new type, pattern or severity, memory and concentration impairment
and unrefreshing sleep.nse.
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multidimensional phenomenon. It is a common denominator referring
to various aspects of impaired physical, mental, emotional and neuro-
cognitive functioning [2–4]. Fatigue is a frequent manifestation of a
variety of medical, neurological and psychiatric conditions but it may
also appear as a side effect of pharmacological treatment.
With regard to fatigue and associated symptoms, the syndromal
deﬁnition of CFS overlaps with other entities such as insomnia [5,6],
obstructive sleep apnea (OSA) [7], ﬁbromyalgia [8] and mood disorders
[9]. The Fukuda case deﬁnition stipulates limited exclusion criteria
within the domain of primary psychiatric disorders, such as past or
present diagnosis of a major depressionwith psychotic features, melan-
cholic depression, bipolar affective disorders, schizophrenia of any
subtype, delusional disorders of any subtype, dementia of any subtype,
and anorexia nervosa or bulimia nervosa [1]. As a result, the presence of
a mood disorder does not exclude a diagnosis of CFS according to the
Fukuda criteria. In this case deﬁnition, however, the extent to which
this disorder needs to be treated is not speciﬁed, whereas the major
criterion requires the absence of a medical or psychiatric disorder that
in itself may sufﬁciently explain abnormal fatigue. Within the primary
sleep disorders, sleep apnea, without indication of severity, and narco-
lepsy are conditions that exclude a diagnosis of CFS [1]. Primary and
secondary insomnia (Diagnostic and Statistical Manual of Mental Disor-
ders 4th edition— text revision, DSM-IV-TR) [10] do not feature within
the Fukuda exclusions, although insomnia can explain the somatic
symptoms in a number of presumed CFS patients [5,11].
Unexplained chronic fatigue (UCF) is best approached from a bio-
psychosocial perspective [12] within a multidisciplinary setting. A
monodisciplinary approach may lead to a spurious diagnosis of CFS as
treatable psychiatric or sleep disorders may go unnoticed.
Patients with UCF in whom previous clinical investigations had not
revealed anymedical or psychiatric diseasewere referred to our tertiary
care center to conﬁrm or exclude a presumed diagnosis of CFS. The aim
of the current study was to identify nosological entities that are either
exclusionary or comorbid to CFS and to assess the prevalence of these
disorders in the group of patients referred with UCF to our center.
Methods
Patient recruitment took place between June 2010 and February
2011. Patients were admitted to our tertiary care referral center for
further clinical investigation of UCF. Prior to referral they had been
examined by conventional methods in primary and/or secondary care
settings. These previous assessments did not reveal any underlying
medical or psychiatric disease that would obviously explain the severity
and duration of the reported chronic fatigue.
Criteria for enrollment were UCF persisting for at least six months,
and a minimum age of 18 years. Participants gave written informed
consent. The study was approved by the institutional Ethical Review
Board of the University Hospital Ghent, Belgium.
Multidisciplinary assessment
Assessment of UCF at our center follows a holistic approach that is
based on the biopsychosocial model by Wessely et al. [12]. The initial
diagnostic part of the integrated diagnostic pathway (Fig. 1) involves
internal medicine assessment, psychodiagnostic screening, rehabilita-
tion assessment, and polysomnography (PSG) combined with a multi-
ple sleep latency test (MSLT). The internal medicine assessment
consists of comprehensive history taking, also considering any previous
medical diagnoses or investigations, and a physical examination. If indi-
cated, routine lab tests, chest radiography and echography of the abdo-
men are carried out. A rehabilitation physician evaluates whether
any musculoskeletal comorbidity is present that is potentially suita-
ble for physiotherapeutic management. Psychodiagnostic screening,
performed by a medical psychologist, includes history taking, theadministration of validated questionnaires (Table 1) and psychological
tests. Psychiatric consultation is scheduled when the history is re-
markable for a past or present psychiatric disorder, and whenever
hints for the presence of a psychiatric disorder emerge from the
psychodiagnostic evaluation or from the multidisciplinary discussion
(Fig. 1). Psychiatric diagnosis complies with DSM-IV-TR criteria [10].
Final diagnosis results from a subsequent multidisciplinary team
discussion with deﬁnition of an individually tailoredmanagement plan.
Sleep assessment
Sleep history is based on an interview that integrates the results
of relevant sleep questionnaires (Table 1). Sleep diagnosis is in keep-
ing with the International Classiﬁcation of Sleep Disorders (ICSD-2)
nosology [13].
PSG and MSLT are recorded and scored according to the American
Academy of Sleep Medicine (AASM) manual [14]. Sleep parameters
derived from PSG include time in bed, total sleep time, sleep efﬁciency,
sleep latency, rapid eye movements (REM) sleep latency, time spent in
the different sleep stages, wakefulness after sleep onset, arousal index,
apnea-hypopnea index (AHI) and presence of periodic limbmovements
(PLM). MSLT consists of taking four naps and assessing mean sleep
latency and presence of REM sleep at sleep onset.
OSA is deﬁned by an AHI ≥ 5/h in combination with associated
symptoms (e.g. excessive daytime sleepiness, fatigue, or impaired
cognition). Severity of OSA is classiﬁed as mild (5 ≤ AHI b 15), moder-
ate (15 ≤ AHI b 30) or severe (AHI ≥ 30).
Patients were asked to withdraw from hypnotics (benzodiazepines
and z-drugs) at least three weeks before PSG was performed.
Diagnostic decision making and categories
The outcome of themultidisciplinary discussion is a diagnostic deci-
sion regarding unequivocal CFS, CFS with comorbidity, or a condition
that excludes CFS.
In unequivocal CFS, no symptoms or signs of coexisting sleep or
psychiatric disorders are observed. CFS with comorbidity is deﬁned as
a combination of UCF meeting the major and minor Fukuda criteria,
with a comorbid condition that may contribute to, but does not sufﬁ-
ciently explain the degree of reported impairment. Typically, coexisting
mood disorder or sleep disorders (e.g. OSA, insomnia, or periodic limb
movement disorder (PLMD)) are being considered ‘comorbid’ in a num-
ber of patients. Predominant sleep and/or psychiatric disorders are
judged exclusionary to CFS, as they tentatively explain the full clinical
picture, including fatigue. In this case, the diagnosis of CFS is not
assumed in the ﬁrst instance, but may be reconsidered in a subsequent
stage, pending insufﬁcient symptomatic relief following adequate treat-
ment of the primary disorder. Nevertheless, this study focuses on the
initial diagnostic classiﬁcation without further follow-up of patients
after treatment.
Diagnostic categories include: 1) CFS without comorbidity
(unequivocal CFS), 2) CFS with comorbidity, 3) a predominant sleep
disorder, 4) a predominant psychiatric disorder, 5) a combination of a
sleep and psychiatric disorder, 6) a classical internal medicine disease
(with or without associated psychiatric or sleep disorders), 7) no ﬁnal
diagnosis (complaints of chronic fatigue remaining unresolved).
Statistical analysis
Descriptive statisticswere performedwith SPSS Statistics version 19.
Results
Inclusion and demographics
Three hundred seventy-seven patients were referred for evaluation of UCF (Fig. 2).
Seven patients (1.9%) were excluded because of the age criterion. Fifty-eight patients
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Fig. 1. Diagnostic pathway for unexplained fatigue. Full lines indicate systematic, interrupted lines indicate optional steps.
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mostly due to cancelation of appointments. In sixteen patients (4.2%), complaints of fa-
tigue had been present for less than six months. Two hundred seventy-nine patients
(74.0%), who met the inclusion criteria, were enrolled in the study.
The majority of the patients was female (n = 237; 84.9%). The mean age was
38.8 years (SD 10.44);mean bodymass index (BMI)was 25.0 kg/m2 (SD 5.19). Aminority
(n = 104; 37.2%) had a certiﬁcate of higher education.
Final diagnoses
An overview of the initial diagnoses is presented in Figs. 2 and 3A.
Of the 279 included patients, 224 (80.3%) met at least four of the minor Fukuda
criteria. Of these, 65 subjects (23.3%) had a ﬁnal diagnosis of unequivocal CFS. In 59
patients (21.1%), CFSwas associatedwith psychiatric disorders (n = 7; 2.5%), sleep disor-
ders (n = 45; 16.1%) or both (n = 7; 2.5%) that were judged comorbid and did not
exclude the diagnosis of CFS. One hundred patients (35.8%), in spite of fulﬁlling the
major and minor criteria of CFS, were diagnosed with another predominant condition,
i.e. a psychiatric disorder (n = 35; 12.5%), a sleep disorder (n = 18; 6.5%), a combination
of both (n = 41; 14.7%), an internal disease with or without sleep or psychiatric comor-
bidity (n = 4; 1.4%), and other conditions (n = 2; 0.7%).
Fifty-ﬁve patients (19.7%) did not meet the minor Fukuda criteria. Eighteen (6.5%)
of these patients had a diagnosis of a predominant psychiatric disorder, 9 (3.2%) had a
predominant sleep disorder, 17 (6.1%) had a combination of both, and 11 (4.0%) had
other conditions.
Only 6 patients (2.2%) of the total sample had a ﬁnal diagnosis pertaining to the
domain of classical internal medicine. Internal disorders consisted of post viral astheniaTable 1
Overview of psychodiagnostic and other questionnaires.
Questionnaire Dimension explored
Symptom checklist-90-revised [33] Psychological distress
Chalder fatigue scale [34] Severity of fatigue
Medical outcomes study 36-item short form
health survey [35]
Global mental and physical health
Epworth sleepiness scale [36] Excessive daytime sleepiness
Pittsburgh sleep quality index [37] Global sleep quality
NEO-ﬁve factor inventory [38] Personality assessment
Checklist individual strength [39] Phenomenology and severity of fatigue
Millon clinical multiaxial inventory [40] Psychopathology(4 patients) and diabetes mellitus (2 patients). In one patient the diabetes was associated
with severe obesity, liver steatosis and hemochromatosis. Moreover, a psychiatric
comorbidity was present in 1 and a sleep disorder in 2 patients of this subgroup.
Sleep disorders
In 242 out of 279 patients (86.7%) the minor criterion of ‘unrefreshing sleep’ was
positive.
Objective sleep assessment revealed (predominant or comorbid) sleep disorders in
139 patients (49.8%) of the total sample. Ninety patients (32.0%) had a single sleep disor-
der, whereas a combination of two and three sleep disorders was present in 46 (16.4%)
and 3 patients (1.1%), respectively.
A wide range of sleep disorders was observed (Fig. 3B), OSA being the most prevalent
(n = 80; 28.7%). Mild, moderate and severe OSAwere diagnosed in 61 (21.9%), 14 (5.0%)
and 5 patients (1.8%), respectively. Other prevalent diagnoses were psychophysiologic
insomnia (n = 43; 15.4%), PLMD (n = 34; 12.2%) and hypnotic dependent sleep disorder
(n = 14; 5.0%).
Psychiatric disorders
In the total sample, a (predominant or comorbid) psychiatric disorder was diagnosed
in 126 patients (45.2%). The majority of these patients (n = 86; 30.8%) had an axis I
diagnosis, 14 (5.0%) had an axis II diagnosis and 26 (9.3%) had a combination of both.
Mood disorder was most prevalent (n = 74; 26.5%), followed by anxiety disorder in
39 patients (14.0%) (Fig. 3C). Sixteen patients (5.7%) had a diagnosis of undifferentiated
somatoform disorder.
Discussion
The present study is remarkable for the ﬁnding that multidisciplin-
ary assessment of UCF conﬁrms unequivocal CFS in only a minority of
patients, and reveals a broad spectrum of exclusionary or comorbid
conditions within the domains of sleep medicine and psychiatry. In
the total group of patients referred to our tertiary care center, different
diagnostic categories were identiﬁed including unequivocal CFS
(23.3%), CFS with signiﬁcant comorbidity that does not invalidate the
diagnosis of CFS (21.1%), predominant sleep disorders (9.7%) and pre-
dominant psychiatric disorders (19.0%).
OSA, being themost prevalent sleep disorder in the recruited patient
sample, was observed in 28.7%. In other CFS referral centers, prevalence
4 minor Fukuda criteria
n = 224
< 4 minor Fukuda criteria
n = 55
Unequivocal CFS
n = 65
CFS with comorbidity
n = 59
CFS excluded
n = 100
•CFS + psychiatric disorder: n = 7
•CFS + sleep disorder: n = 45
•CFS + both: n = 7
•Psychiatric disorder: n = 35
•Sleep disorder: n = 18
•Psychiatric + sleep disorder: n = 41
•Internal disease: n = 4
(1 psychiatric and 2 sleep disorders)
•Other condition: n = 2
Psychiatric disorder
n = 18
Sleep disorder
n = 9
Psychiatric + Sleep 
disorder
n = 17
Other condition
n = 11
•Internal disease: n = 2
•Other condition: n = 2
•No final diagnosis: n = 7
Patients referred for evaluation of CF
n = 377
Patients with presumed CFS
n = 279
Exclusion: 
•< 18 years: n = 7
•No informed consent: n = 58
•Insufficient data available: n = 17
•No fatigue > 6 months: n = 16
Fig. 2. Flow chart of patients referred for evaluation of unexplained chronic fatigue, and ﬁnal diagnoses in patients with presumed CFS.
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comorbid, or even an exclusionary disorder that is to be considered in
the differential diagnosis of CFS. The prevalence of OSA is estimated
4% in men and 2% in women in the general population [17]. Patients
with UCF are often sedentary and even bedridden [18], which might
predispose them to obesity and sleep-disordered breathing [19].
However, theweight status of the present patient sample approximates
normalcy (mean BMI 25.0 kg/m2) and is similar to that of the overall
Belgian adult population (mean BMI 25.3 kg/m2) [20]. This ﬁnding is
in accordance with limited published data which suggest that patients
with chronic unexplained fatigue and CFS are not excessively over-
weight or obese [21]. Interestingly, the high prevalence of OSA in our
patient group is in parallel with the rates of unrelated clinical samples,
such as arterial hypertension (30–85%), congestive heart failure
(20–50%), and metabolic syndrome (82%) [22]. The use of PSG to
identify OSA has been advocated in clinical populations at risk for
OSA [23], and seems from the present data also recommendable in
CFS patients.
Insomnia was observed in a relatively small number of enrolled
patients (15.4%)which is in contrastwith data from the general popula-
tion that demonstrate a higher prevalence (27.2%) [24]. Thismay be due
to selection bias, because patients with a clear history of insomnia are
directly being referred for dedicated insomnia-treatment in our hospi-
tal. Similarly, hypnotic-dependent sleep disorders (5.0%) may also be
underrepresented because patients were asked to withdraw from
sleeping pills before PSG was carried out.
Hitherto, a strong connection between CFS and psychiatric disorders
has been reported. In a community-based study, Nater et al. found that
57% of individualswith CFS had at least one current and 89%one lifetime
psychiatric diagnosis [25]. In clinical CFS patients, signiﬁcant coexis-
tence with psychiatric disease was found [26–29]. However, in our
patient sample, we mostly observed diagnoses of mood disorder and
anxiety disorder, that actually exclude CFS (40.2%), whereas psychiatric
disturbances that do not invalidate the diagnosis of CFS were less
frequent (5.0%). The predominance of exclusionary over comorbid
psychiatric disorders probably resulted from the formal psychodiagnosticevaluation, psychiatric diagnostic work-up and multidisciplinary discus-
sion. As a consequence, we contend that insufﬁciently recognized psychi-
atric morbidity should be addressed prior to labeling chronic fatigue as
CFS.
Data on prevalence rates of personality disorder in CFS patients are
inconsistent. Previously reported ﬁgures ranging between 28 and 39%
[26–28,30] were not conﬁrmed by Courjaret et al. [31] and by Kempke
et al. [32] who found that, respectively, in only 12% and 16% of female
CFS patients a personality disorder could be identiﬁed. In the present
sample, the prevalence of personality disorder (especially cluster B
and C) amounted to 14.3%, which approximates the latter ﬁgures.
Differences in methodology, including sample size, selection bias and
the use of different self-report questionnaires, may explain the variety
in prevalences among different studies.
Diagnoses pertaining to classical internal medicine are scarce in our
sample, probably because they already had been detected at the level of
primary or secondary care. This ﬁndingwould imply that, at the tertiary
care level, there is no need for repeating extensive medical tests to
detect underlying internal diseases. With respect to health policies
pertaining to CFS, it is recommended to limit laboratory and imaging
tests in terms of number and reiteration.
Obviously, the present reclassiﬁcation of presumed CFS into catego-
ries of unequivocal CFS, comorbid CFS and exclusionary conditions is the
result of a systematic and integratedmultidisciplinary approach, includ-
ing internal medicine, medical psychology, psychiatry, and rehabilita-
tion medicine. As such, this approach differs from monodisciplinary
case management, that tends to label medically unexplained symptoms
(MUS) into organ- or specialty driven syndromal deﬁnitions, e.g. irrita-
ble bowel syndrome, ﬁbromyalgia, and myalgic encephalomyelitis.
Unraveling the intricacies of MUS is not a focus of interest for many
general practitioners and organ specialists. Often, the characteristics of
precipitating and perpetuating factors that are operational in MUS are
insufﬁciently documented. Moreover, salient comorbidity in the
domains of psychopathology and sleep medicine may go unnoticed.
From our data, it is clear that a tendency to prematurely establish a
diagnosis of CFS, carries a risk of underdiagnosis of other treatable
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Fig. 3.A, B, C: Relative prevalence of (A)ﬁnal diagnosis; (B) sleepdisorders, (C) psychiatric
disorders in patients with presumed CFS. Idiop. hypersom.: Idiopathic hypersomnia.
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fatigue, such as ours, may provide means to reorient patients towards
integrated care programs based on multimodal therapy, taking into ac-
count previously undetected psychiatric and/or sleep disorders. At the
same time, this approach may serve as a corrective tool against
overlabeling with non-validated syndromal deﬁnitions. The wide
range of treatable disorders that is found in the present sample may
serve as a justiﬁcation for the need to systematically assess clinical CFS
patients in a multidisciplinary setting.
A limitation of this study is the lack of follow-up of patients after
treatment. Assessment in our center is part of a regional network of
care. Our intervention focuses primarily on the diagnostic pathway,
and a number of patients are subsequently referred back to the treatingphysician. Therefore, systematic follow-up data on the effect of recom-
mended treatment regimens are not available. The report hence focuses
on the initial diagnostic classiﬁcation, which could be subject to adjust-
ment following reassessment after the therapeutic phase.
Secondly, we recognize a potential physician bias in deﬁning primary
versus comorbid disorders in the present patient sample. However, in
the current diagnostic process, this may be attenuated by the multi-
disciplinary approach, which strengthens internal consistency.
Last, the Fukuda exclusion criteria were used in diagnosing CFS
instead of the CDC recommendations published in 2003 [41]. Never-
theless, since only few subjects of the present patient population
presented with a permanent, lifetime exclusion as indicated in the
Fukuda deﬁnition, we contend that the use of the 2003 CDC recom-
mendations would only have had a minor effect on the classiﬁcation
in the presented diagnostic categories.
In conclusion, amultidisciplinary approach to patientswith presumed
CFS referred to a tertiary care center seemsnecessary in order to identify a
wide range of diagnostic categories relevant to appropriate care. A high
prevalence of predominant sleep and psychiatric disorders is found.
These ﬁndings favor thorough screening including psychodiagnostic
testing, formal psychiatric diagnosis and objective assessment of sleep
parameters in patients with presumed CFS.
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